
← PharmOncology5 Aug · 12 min
Why current HER2 testing is flawed
Why current HER2 testing is flawed
<p>Problems with how we currently test for HER2 and possible future directions.</p><p><br></p><p>Trastuzumab in endometrial cancer: https://pmc.ncbi.nlm.nih.gov/articles/PMC8792803/Issues with HER2 testing in endometrial cancer: </p><p><a href="https://www.gynecologiconcology-online.net/article/S0090-8258(25)01072-8/fulltext">https://www.gynecologiconcology-online.net/article/S0090-8258(25)01072-8/fulltext</a></p><p>https://www.mdpi.com/2072-6694/18/12/2009Novel methods of testing for HER2: <a href="https://www.nature.com/articles/s41698-026-01365-6">https://www.nature.com/articles/s41698-026-01365-6</a></p>